Stifel Starts agilon health Inc (AGL) at Buy

December 8, 2022 4:14 PM EST
Get Alerts AGL Hot Sheet
Price: $22.05 -2.48%

Rating Summary:
    15 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 32 | New: 9
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Stifel analyst Craig Jones initiates coverage on agilon health Inc (NYSE: AGL) with a Buy rating and a price target of $23.00.

The analyst comments "agilon's platform enables established primary care provider groups to transition to value-based care by taking full risk on their Medicare Advantage patients. agilon offers relatively high exposure to the US healthcare transition to value-based care on a platform model that is very capex and opex light. We expect agilon to continue to grow 30%+ in the medium term while expanding margins and to begin generating cash in 2023, with $1 billion in cash and no debt on the balance sheet."

For an analyst ratings summary and ratings history on agilon health Inc click here. For more ratings news on agilon health Inc click here.

Shares of agilon health Inc closed at $17.08 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities